We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Based on 27 analysts
Target prices reflect the market consensus (mean/high/low), not individual research firms. 52 actions collected · 52 in the last 12 months.
Auto-generated summary combining US and Korean research and earnings · not investment advice
Eli Lilly (LLY) is currently trading at $1105, and the consensus target price from 28 analysts is $1254.07, which is higher than the current price. Recent analyst opinions have all maintained positive ratings such as 'Buy', 'Outperform', and 'Overweight'. However, the lowest target price suggested is $850, which is below the current price. Overall, analysts are showing a positive outlook.
Divergence: US analysts consistently maintain positive opinions regarding Eli Lilly.
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 07. 16. | Citigroup | — | Maintain | Buy → Buy | — | Citigroup: Buy |
| 2026. 07. 14. | Bernstein | — | Maintain | Outperform → Outperform | — | Bernstein: Outperform |
| 2026. 07. 14. | UBS | — | Maintain | Buy → Buy | — | UBS: Buy |
| 2026. 07. 13. | Guggenheim | — | Maintain | Buy → Buy | — | Guggenheim: Buy |
| 2026. 07. 11. | B of A Securities | — | Maintain | Buy → Buy | — | B of A Securities: Buy |
| 2026. 07. 09. | Truist Securities | — | Maintain | Buy → Buy | — | Truist Securities: Buy |
| 2026. 07. 09. | Morgan Stanley | — | Maintain | Overweight → Overweight | — | Morgan Stanley: Overweight |
| 2026. 07. 08. | RBC Capital | — | Maintain | Outperform → Outperform | — | RBC Capital: Outperform |
| 2026. 07. 07. | JP Morgan | — | Maintain | Overweight → Overweight | — | JP Morgan: Overweight |
| 2026. 07. 06. | Cantor Fitzgerald | — | Maintain | Overweight → Overweight | — | Cantor Fitzgerald: Overweight |
| 2026. 06. 26. | Leerink Partners | — | Maintain | Outperform → Outperform | — | Leerink Partners: Outperform |
| 2026. 06. 10. | Jefferies | — | Maintain | Buy → Buy | — | Jefferies: Buy |
| 2026. 05. 27. | B of A Securities | — | Maintain | Buy → Buy | — | B of A Securities: Buy |
| 2026. 05. 05. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2026. 05. 05. | Guggenheim | — | Maintain | Buy → Buy | — | Guggenheim: Buy |
| 2026. 05. 05. | Wolfe Research | — | Maintain | Outperform → Outperform | — | Wolfe Research: Outperform |
| 2026. 05. 02. | Cantor Fitzgerald | — | Maintain | Overweight → Overweight | — | Cantor Fitzgerald: Overweight |
| 2026. 04. 22. | Guggenheim | — | Maintain | Buy → Buy | — | Guggenheim: Buy |
| 2026. 04. 11. | Morgan Stanley | — | Maintain | Overweight → Overweight | — | Morgan Stanley: Overweight |
| 2026. 04. 02. | B of A Securities | — | Maintain | Buy → Buy | — | B of A Securities: Buy |
| 2026. 03. 30. | Guggenheim | — | Maintain | Buy → Buy | — | Guggenheim: Buy |
| 2026. 03. 18. | HSBC | — | Downgrade | Hold → Reduce | — | HSBC: Hold → Reduce |
| 2026. 02. 25. | RBC Capital | — | Initiate coverage | — → Outperform | — | RBC Capital: Outperform |
| 2026. 02. 20. | Barclays | — | Initiate coverage | — → Overweight | — | Barclays: Overweight |
| 2026. 02. 10. | Freedom Broker | — | Upgrade | Hold → Buy | — | Freedom Broker: Hold → Buy |
| 2026. 02. 09. | Deutsche Bank | — | Maintain | Buy → Buy | — | Deutsche Bank: Buy |
| 2026. 02. 06. | JP Morgan | — | Maintain | Overweight → Overweight | — | JP Morgan: Overweight |
| 2026. 02. 05. | Cantor Fitzgerald | — | Maintain | Overweight → Overweight | — | Cantor Fitzgerald: Overweight |
| 2026. 02. 05. | Wells Fargo | — | Maintain | Overweight → Overweight | — | Wells Fargo: Overweight |
| 2026. 02. 05. | Morgan Stanley | — | Maintain | Overweight → Overweight | — | Morgan Stanley: Overweight |
| 2026. 02. 02. | Freedom Broker | — | Maintain | Hold → Hold | — | Freedom Broker: Hold |
| 2026. 01. 20. | Guggenheim | — | Maintain | Buy → Buy | — | Guggenheim: Buy |
| 2025. 12. 15. | B of A Securities | — | Maintain | Buy → Buy | — | B of A Securities: Buy |
| 2025. 12. 11. | Wells Fargo | — | Maintain | Overweight → Overweight | — | Wells Fargo: Overweight |
| 2025. 12. 04. | BMO Capital | — | Maintain | Outperform → Outperform | — | BMO Capital: Outperform |
| 2025. 12. 04. | Guggenheim | — | Maintain | Buy → Buy | — | Guggenheim: Buy |
| 2025. 11. 25. | Morgan Stanley | — | Maintain | Overweight → Overweight | — | Morgan Stanley: Overweight |
| 2025. 11. 25. | Bernstein | — | Maintain | Outperform → Outperform | — | Bernstein: Outperform |
| 2025. 11. 20. | Truist Securities | — | Maintain | Buy → Buy | — | Truist Securities: Buy |
| 2025. 11. 19. | JP Morgan | — | Maintain | Overweight → Overweight | — | JP Morgan: Overweight |
| 2025. 11. 13. | Morgan Stanley | — | Maintain | Overweight → Overweight | — | Morgan Stanley: Overweight |
| 2025. 11. 13. | Citigroup | — | Maintain | Buy → Buy | — | Citigroup: Buy |
| 2025. 11. 11. | Freedom Broker | — | Downgrade | Buy → Hold | — | Freedom Broker: Buy → Hold |
| 2025. 11. 10. | Leerink Partners | — | Upgrade | Market Perform → Outperform | — | Leerink Partners: Market Perform → Outperform |
| 2025. 11. 08. | UBS | — | Maintain | Buy → Buy | — | UBS: Buy |
| 2025. 11. 06. | BMO Capital | — | Maintain | Outperform → Outperform | — | BMO Capital: Outperform |
| 2025. 10. 31. | Cantor Fitzgerald | — | Maintain | Overweight → Overweight | — | Cantor Fitzgerald: Overweight |
| 2025. 10. 16. | Guggenheim | — | Maintain | Buy → Buy | — | Guggenheim: Buy |
| 2025. 10. 08. | Guggenheim | — | Maintain | Buy → Buy | — | Guggenheim: Buy |
| 2025. 10. 03. | Morgan Stanley | — | Maintain | Overweight → Overweight | — | Morgan Stanley: Overweight |
| 2025. 09. 17. | Berenberg | — | Downgrade | Buy → Hold | — | Berenberg: Buy → Hold |
| 2025. 09. 16. | JP Morgan | — | Maintain | Overweight → Overweight | — | JP Morgan: Overweight |